Capital Research Global Investors — VRTX Trade History
Quarter-by-quarter changes in the VERTEX PHARMACEUTICALS INC position · CUSIP 92532F100
Currently held · 3.5 YearsFirst seen: 2018 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-12 | Reduce | 19,490,637 | -1,635,327 | -7.7% | $9.68B | 1.35% |
| 2026 Q1 | 2026-05-13 | Add | 21,125,964 | 3,809,620 | +22.0% | $9.43B | 1.46% |
| 2025 Q4 | 2026-02-11 | Add | 17,316,344 | 763,063 | +4.6% | $7.85B | 1.45% |
| 2025 Q3 | 2025-11-13 | Add | 16,553,281 | 444,990 | +2.8% | $6.48B | 1.22% |
| 2025 Q2 | 2025-08-13 | Add | 16,108,291 | 1,571,947 | +10.8% | $7.17B | 1.44% |
| 2025 Q1 | 2025-05-12 | Add | 14,536,344 | 4,107,393 | +39.4% | $7.05B | 1.53% |
| 2024 Q4 | 2025-02-13 | Add | 10,428,951 | 1,426,746 | +15.8% | $4.20B | 0.86% |
| 2024 Q3 | 2024-11-13 | Add | 9,002,205 | 462,866 | +5.4% | $4.19B | 0.87% |
| 2024 Q2 | 2024-08-13 | Add | 8,539,339 | 2,795,457 | +48.7% | $4.00B | 0.88% |
| 2024 Q1 | 2024-05-14 | Add | 5,743,882 | 2,176,218 | +61.0% | $2.40B | 0.54% |
| 2023 Q4 | 2024-02-13 | Add | 3,567,664 | 195,080 | +5.8% | $1.45B | 0.36% |
| 2023 Q3 | 2023-11-13 | Add | 3,372,584 | 310,908 | +10.2% | $1.17B | 0.32% |
| 2023 Q2 | 2023-08-11 | Add | 3,061,676 | 2,251,781 | +278.0% | $1.08B | 0.29% |
| 2023 Q1 | 2023-05-15 | New | 809,895 | 809,895 | — | $255.2M | 0.07% |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-15 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-19 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-15 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | Sold out | — | -1,250,658 | -100.0% | — | — |
| 2020 Q3 | 2020-11-13 | Reduce | 1,250,658 | -1 | -0.0% | $340.3M | 0.10% |
| 2020 Q2 | 2020-08-14 | Reduce | 1,250,659 | -5 | -0.0% | $363.1M | 0.12% |
| 2020 Q1 | 2020-05-15 | Add | 1,250,664 | 15 | +0.0% | $297.6M | 0.12% |
| 2019 Q4 | 2020-02-18 | Add | 1,250,649 | 379 | +0.0% | $273.8M | 0.08% |
| 2019 Q3 | 2019-11-14 | Add | 1,250,270 | 22 | +0.0% | $211.8M | 0.07% |
| 2019 Q2 | 2019-08-14 | Add | 1,250,248 | 248 | +0.0% | $229.3M | 0.07% |
| 2019 Q1 | 2019-05-15 | Reduce | 1,250,000 | -815,018 | -39.5% | $229.9M | 0.07% |
| 2018 Q4 | 2019-02-14 | New | 2,065,018 | 2,065,018 | — | $342.2M | 0.12% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.